Natera News, Natera Quote, NTRA Quote

Natera (NQ:NTRA) Delayed: 90.32 -0.1 (0.11%)

Prev. Close

$90.42

Open

$90.71

52 Wk High

$13.80

52 Wk Low

$6.52

Day High

$91.50

Day Low

$89.72

P/E

N/A

EPS

$0.00

Volume

1,339,301

Friends, Peers and Foes (?): CDNA, NVTA, NEO, TMO, BHVN (more...)

Apr 15, 2024 04:19 PM Form 144 Natera, Inc. Filed by: Chapman Steven Leonard
Apr 15, 2024 06:21 AM Natera (NTRA) PT Raised to $100 at Goldman Sachs
Apr 11, 2024 08:00 AM Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
Apr 8, 2024 08:14 AM Craig-Hallum Assumes Natera (NTRA) at Buy
Apr 8, 2024 08:00 AM Natera (NTRA) Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Apr 8, 2024 08:00 AM Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Apr 5, 2024 03:22 PM Natera (NTRA) call put ratio 3.5 calls to 1 put as share price up 5.1%
Apr 5, 2024 07:00 AM Natera (NTRA) Reports Positive Surveillance Analysis from Phase III IMvigor011 Trial
Apr 5, 2024 07:00 AM Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
Apr 5, 2024 05:11 AM Bernstein SocGen Group Upgrades Natera (NTRA) to Outperform

Entities mentioned with NTRA